WHO Halts Trial of Malaria Drug Hydroxychloroquine in Coronavirus Patients
File photo of the drug hydroxychloroquine. (Reuters)
The World Health Organization said that testing of the drug in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.
The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.
"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.
LIVE TV
